Regulating a Miracle Drug: GLP-1 Costs, Access, & Safety Understanding GLP-1 Drugs: Cost, Safety, and Access in Context New Weight Loss Drugs (GLP-1s) Explained: Science, Impact, Potential Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders Disclaimer: The information provided on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
The leading drugs in this category are Mounjaro (tirzepatide), Ozempic (semaglutide), and Rybelsus, which is the oral form of semaglutide
increase the peripheral response to insulin, improving insulin sensitivity
Clinicians sometimes hold a dose longer before increasing to the next step
Diarrhea is expected during dose escalation and resolves for most users